Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Reviewers criticized the study for its assumptions, social media data collection issues, and lack of comparison to existing methods.

Higher SRD5A2 expression predicts better response to finasteride in treating urinary symptoms.

Patients and doctors often disagree on alopecia areata severity and treatment satisfaction.

Most women continued using oral minoxidil for hair loss despite mild to moderate side effects.

Most patients know about minoxidil for hair loss, but concerns about its use and effectiveness affect their decision to use it.

Media attention increased oral minoxidil prescriptions for English-preferring patients but not for Spanish-preferring patients.

Hantavirus survivors often face long-term health issues, needing ongoing care.

The letter criticizes a study's methods and small size, suggesting larger, better-designed research would show low-level light therapy effectively grows hair.

Liquid Nitrogen Cryotherapy effectively treats unresponsive Alopecia Areata with minimal side effects.

Using a call center to collect data in a trial for eye disease in diabetics led to high response rates and very little missing information.

Most patients with rheumatoid arthritis continued methotrexate treatment over two years, but those who stopped and restarted experienced more side effects and less improvement.

A transman experienced lasting virilization symptoms after stopping testosterone, which were resolved with estradiol treatment.

The reply suggests checking for false positive or asymptomatic syphilis and using penicillin for treatment if necessary.

Bexxar treatment led to a high response rate in patients with advanced-stage, treatment-resistant follicular lymphoma.

Finasteride works better for hair loss in patients 26 or younger.

SRD5A2 methylation in blood can predict how well someone will respond to finasteride treatment.

Chronic refractory alopecia areata has more skin-resident memory T cells, and JAK inhibitors may help reduce them.

Continued ritlecitinib treatment helps sustain hair regrowth in alopecia areata patients.

Baricitinib helped regrow hair in patients with severe alopecia areata after other treatments failed.

Increasing the dose of baricitinib to 4 mg helps more patients with severe alopecia areata regrow hair.

Using cosmetics made elderly people feel more comfortable and attractive.

People with hair loss have different lifestyles and various things influence whether they want treatment.

Patients with fewer past treatments for alopecia areata respond better to baricitinib.

The conclusion is that maintaining blinding in clinical trials is crucial for reliable results.

Finasteride for hair loss may cause persistent sexual symptoms, depression, anxiety, and lower quality of life.

Patients with certain baseline characteristics are more likely to benefit early from baricitinib for alopecia areata.

Post-finasteride syndrome may be linked to pre-existing psychological issues, not just the drug.